In the US, Posaconazole (posaconazole systemic) is a member of the drug class azole antifungals and is used to treat Aspergillosis - Invasive, Candida Infections - Systemic and Oral Thrush.
US matches:
- Posaconazole Suspension
- Posaconazole
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J02AC04
CAS registry number (Chemical Abstracts Service)
0171228-49-2
Chemical Formula
C37-H42-F2-N8-O4
Molecular Weight
700
Therapeutic Category
Antifungal agent
Chemical Names
(3R-cis)-4-[4-[4-[4-[5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-ylmethoxy]-phenyl]piperazin-1-yl]phenyl]-2-[1(S)-ethyl-2(S)-hydroxypropyl]-3,4-dihydro-2H-1,2,4 -triazol-3-one
1-[(1S,2S)Ethyl-2-hydroxypropyl]-2,3-dihydro-4-{4-[4-(4-{2-[(2S,4R)-(1,2,4-triazol-1-ylmethyl)-2-(2,4-difluorphenyl)oxolan-4-ylmethyl]phenyl}piperazin-1-yl)phenyl]}-1,2,4-triazol-3-on (IUPAC)
2,5-Anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-(4-[1-(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol
3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-yl-methyl)-3-furanyl]methoxy]phenyl]-1-piperazinyl]phenyl]-2-(1-ethyl-2-hydroxypropyl)-2,4-dihydro-, [3R-[3α(1S*,2S*),5α]]- (USAN)
4-[4-(4-{4-[(3R,5R)-5-]2,4-Difluorophenyl}tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)-3-furylmethoxy]phenyl}piperazin-1-yl)phenyl]-2-[(1S,2S)-1-ethyl-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one (BAN)
4-[p-[4-[p-[[(3R,5R)-5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)-3-furyl]methoxy]phenyl]-1-piperazinyl]phenyl]-1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-delta²-1,2,4-triazolin-5-one (WHO)
Foreign Names
- Posaconazolum (Latin)
- Posaconazol (German)
- Posaconazole (French)
- Posaconazol (Spanish)
Generic Names
- Posaconazole (OS: USAN, BAN)
- SCH 56592 (IS: ScheringPlough)
Brand Names
- Noxafil
Essex, Germany; Essex Chemie, Switzerland; Sanofi-Aventis, Croatia (Hrvatska); Schering, Belgium; Schering, Czech Republic; Schering, United States; Schering-Plough, Australia; Schering-Plough, Spain; Schering-Plough, Finland; Schering-Plough, France; Schering-Plough, United Kingdom; Schering-Plough, Hungary; Schering-Plough, Ireland; Schering-Plough, Italy; Schering-Plough, Netherlands; Schering-Plough, Norway; Schering-Plough, Sweden; Schering-Plough, Slovenia; Schering-Plough, Slovakia; SP Europe, Austria; SP Europe, Denmark - Posanol
Schering-Plough, Canada
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment